INS and Hypoglycemia: An investigational Medtronic device with the PLGM feature was assessed by Abraham et al. in experiments of insulin-induced [33] and exercise-induced [34] hypoglycemia and under real-life conditions [43, 45], demonstrating the effectiveness of the algorithm in reducing hypoglycemia and hypotreatment requirements.